Cargando…

Persistence of radiation-induced aberrations in patients after radiotherapy with C-ions and IMRT

BACKGROUND AND PURPOSE: Chromosomal aberrations in peripheral blood lymphocytes are a biomarker for radiation exposure and are associated with an increased risk for malignancies. To determine the long-term cytogenetic effect of radiotherapy, we analyzed the persistence of different aberration types...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartel, Carola, Nasonova, Elena, Fuss, Martina C., Nikoghosyan, Anna V., Debus, Juergen, Ritter, Sylvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198102/ https://www.ncbi.nlm.nih.gov/pubmed/30364751 http://dx.doi.org/10.1016/j.ctro.2018.10.002

Ejemplares similares

Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12)
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Chromosome Aberrations in Lymphocytes of Patients Undergoing Radon Spa Therapy: An Explorative mFISH Study
por: Paz, Nerea, et al.
Publicado: (2021)

Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC
por: Jensen, Alexandra D, et al.
Publicado: (2010)

Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux(® )and particle therapy]
por: Jensen, Alexandra D, et al.
Publicado: (2011)

IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial
por: Jensen, Alexandra D, et al.
Publicado: (2012)

Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma
por: Adeberg, Sebastian, et al.
Publicado: (2019)

The effect of X-rays and C-ions on pluripotent embryonic stem cells
por: Luft, Sabine, et al.
Publicado: (2014)

Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment
por: Münter, MW, et al.
Publicado: (2006)

A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma
por: Roeder, Falk, et al.
Publicado: (2012)

Clinical Phase I/II trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis
por: Roeder, Falk, et al.
Publicado: (2014)

Spontaneous and Radiation-Induced Chromosome Aberrations in Primary Fibroblasts of Patients With Pediatric First and Second Neoplasms
por: Zahnreich, Sebastian, et al.
Publicado: (2020)

Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III - The OVAR-IMRT-02 Study
por: Rochet, Nathalie, et al.
Publicado: (2011)

Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer
por: Roeder, Falk, et al.
Publicado: (2014)

Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma
por: Combs, Stephanie E, et al.
Publicado: (2007)

Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity
por: Lang, Kristin, et al.
Publicado: (2018)

Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis
por: Askoxylakis, Vasileios, et al.
Publicado: (2016)

Cost-effectiveness analysis (CEA) of IMRT plus C12 boost vs IMRT only in adenoid cystic carcinoma (ACC) of the head and neck
por: Jensen, A D, et al.
Publicado: (2019)

Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy—GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study
por: König, Laila, et al.
Publicado: (2021)

Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol
por: Rochet, Nathalie, et al.
Publicado: (2007)

Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer – a retrospective single center analysis
por: Saleh-Ebrahimi, Ladan, et al.
Publicado: (2013)

Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme
por: Fuller, Clifton D, et al.
Publicado: (2007)

Comparison of chromosomal damage induced by low and high LET radiation
por: Nasonova, E A, et al.
Publicado: (1995)

Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas
por: Kosaki, Katsura, et al.
Publicado: (2012)

Carbon ion therapy for ameloblastic carcinoma
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study
por: Nikoghosyan, Anna V, et al.
Publicado: (2010)

Intensity modulated radiotherapy (IMRT) in bilateral retinoblastoma
por: Atalar, Banu, et al.
Publicado: (2010)

Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study
por: Nikoghosyan, Anna V, et al.
Publicado: (2010)

Intensity modulated radiotherapy (IMRT) in the treatment of children and Adolescents - a single institution's experience and a review of the literature
por: Sterzing, Florian, et al.
Publicado: (2009)

Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer
por: Liermann, Jakob, et al.
Publicado: (2021)

Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes
por: Combs, Stephanie E, et al.
Publicado: (2006)

Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Effectiveness of Carbon Ion Radiation in Locally Advanced Pancreatic Cancer
por: Liermann, Jakob, et al.
Publicado: (2021)

Production and distribution of chromosome aberrations in human lymphocytes by particle beams with different LET
por: Kowalska, Agata, et al.
Publicado: (2019)

Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Impact of Target Oxygenation on the Chemical Track Evolution of Ion and Electron Radiation
por: Boscolo, Daria, et al.
Publicado: (2020)

Spontaneous and radiation-induced chromosomal instability and persistence of chromosome aberrations after radiotherapy in lymphocytes from prostate cancer patients
por: Hille, Andrea, et al.
Publicado: (2009)

Intensity modulated radiotherapy (IMRT) in benign giant cell tumors -- a single institution case series and a short review of the literature
por: Roeder, Falk, et al.
Publicado: (2010)

Comparison of chromosomal damage induced by X-rays and Ar ions with an LET of 1840 keV/$\mu$m in G$_{1}$-phase V79 cells
por: Ritter, S, et al.
Publicado: (1995)

Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma
por: Blattmann, Claudia, et al.
Publicado: (2010)

The Effect of X-Ray and Heavy Ions Radiations on Chemotherapy Refractory Tumor Cells
por: Yu, Zhan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l86hdpujkci7u7nnmc666420hl